|
PGBD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.101900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.568400E-01 |
| Normal-vs-Stage2 |
4.370000E-01 |
| Normal-vs-Stage3 |
2.185700E-02 |
| Normal-vs-Stage4 |
5.260600E-03 |
| Stage1-vs-Stage2 |
4.957200E-01 |
| Stage1-vs-Stage3 |
4.601800E-02 |
| Stage1-vs-Stage4 |
1.079590E-02 |
| Stage2-vs-Stage3 |
5.295800E-01 |
| Stage2-vs-Stage4 |
2.312400E-01 |
| Stage3-vs-Stage4 |
4.273400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.741800E-02 |
| Normal-vs-AfricanAmerican |
7.780600E-01 |
| Normal-vs-Asian |
8.189800E-01 |
| Caucasian-vs-AfricanAmerican |
4.655400E-01 |
| Caucasian-vs-Asian |
5.151000E-01 |
| AfricanAmerican-vs-Asian |
7.620400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.639200E-03 |
| Normal-vs-Female |
8.194600E-01 |
| Male-vs-Female |
5.576300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.260400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.823400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.906400E-02 |
| Normal-vs-Age(81-100Yrs) |
4.610600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.701800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.217600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.593800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.389900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.503800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.872000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.597000E-01 |
| Normal-vs-Grade 2 |
9.831800E-01 |
| Normal-vs-Grade 3 |
2.736100E-02 |
| Normal-vs-Grade 4 |
1.059530E-03 |
| Grade 1-vs-Grade 2 |
5.465200E-01 |
| Grade 1-vs-Grade 3 |
1.595780E-01 |
| Grade 1-vs-Grade 4 |
3.142200E-02 |
| Grade 2-vs-Grade 3 |
3.075900E-02 |
| Grade 2-vs-Grade 4 |
1.464740E-03 |
| Grade 3-vs-Grade 4 |
9.268200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.395600E-01 |
| Normal-vs-ccB subtype |
1.246120E-02 |
| ccA subtype-vs-ccB subtype |
2.233700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.489000E-01 |
| Normal-vs-N1 |
1.993580E-02 |
| N0-vs-N1 |
6.541500E-02 |
|
|
